Cage Bio

San Carlos, CA · Privately Held (backing)

Developer of an eutectic ionic liquid designed to minimize the pervasive use of systemic drugs for the treatment of dermal diseases and symptoms. Cage Bio is based in San Carlos, CA. Its last reported valuation was $125 million in Jun 2019. It has raised $57.6 million across 3 recorded rounds; the latest was an $11 million early-stage round in Apr 2024.

Last reported valuation
$125.0M
Oct 2026
Priced at
—
Total raised
$57.6M
Last round
Early Stage VC
Apr 2024

Who backs Cage Bio?

6 investors
InvestorType
Johnson & Johnson Innovation - JLABSOther
AG Collective Capital—
CKG Management—
HSC Next—
MBC BioLabs—
TexCag—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Cage Bio investors

6 investors are on record for Cage Bio, including Johnson & Johnson Innovation - JLABS, AG Collective Capital, CKG Management and HSC Next. The early-stage round in Apr 2024 drew 14 investors.

Free account
More of Cage Bio with a free account
  • ·Watch Cage Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Cage Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View